Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 1 | 1 | 4 | 4 | 7,005 |
| Cost of Goods | N/A | 0 | 0 | 0 | 1,050 |
| Gross Profit | 1 | 2 | 4 | 4 | 5,950 |
| Operating Expenses | 4,756 | 4,740 | 5,010 | 4,110 | 2,800 |
| Operating Income | -4,755 | -4,739 | -5,006 | -4,106 | 3,205 |
| Interest Expense | 173 | 10 | 370 | 0 | 0 |
| Other Income | 286 | -581 | 1,146 | -414 | 165 |
| Pre-tax Income | -4,642 | -5,330 | -4,230 | -4,520 | 3,370 |
| Net Income Continuous | -4,642 | -5,328 | -4,236 | -4,524 | 3,377 |
| Net Income | $-4,642 | $-5,328 | $-4,236 | $-4,524 | $3,377 |
| EPS Basic Total Ops | -500.00 | -600.00 | -500.00 | -520.00 | 410.00 |
| EPS Basic Continuous Ops | -495.52 | -605.45 | -498.35 | -514.09 | 411.83 |
| EPS Diluted Total Ops | -500.00 | -600.00 | -500.00 | -520.00 | 390.00 |
| EPS Diluted Continuous Ops | -495.52 | -605.45 | -498.35 | -514.09 | 388.16 |
| EBITDA(a) | $-4,746 | $-4,779 | $-5,006 | $-4,096 | $3,255 |